EDEX- alprostadil injection, powder, lyophilized, for solution

Country: United States

Language: English

Source: NLM (National Library of Medicine)

Buy It Now

Active ingredient:

ALPROSTADIL (UNII: F5TD010360) (ALPROSTADIL - UNII:F5TD010360)

Available from:

Endo Pharmaceuticals Inc.

INN (International Name):

ALPROSTADIL

Composition:

ALPROSTADIL 10 ug in 1 mL

Administration route:

INTRACAVERNOUS

Prescription type:

PRESCRIPTION DRUG

Therapeutic indications:

edex® is indicated for the treatment of erectile dysfunction due to neurogenic, vasculogenic, psychogenic, or mixed etiology. edex® should not be used: - in men who have conditions that predispose them to priapism, such as sickle cell anemia or sickle cell trait, multiple myeloma, or leukemia [see WARNINGS]. - for the treatment of erectile dysfunction in men with fibrotic conditions of the penis, such as cavernosal fibrosis or Peyronie’s disease [see PRECAUTIONS]   - in men with penile implants

Product summary:

edex® (alprostadil for injection) is available in single-dose, dual-chamber cartridges intended for use with the reusable edex® injection device. One chamber of the cartridge contains 10.75, 21.5, or 43 mcg of alprostadil as a white, sterile, lyophilized powder. The other chamber contains 1.075 mL of sterile 0.9% sodium chloride. When the cartridge is placed into the edex® injection device and reconstituted, the deliverable amount of alprostadil in each milliliter is 10, 20, or 40 mcg, respectively. edex® Cartridge 2 Pack contains one reusable edex® injection device, two single-dose, dual-chamber cartridges, two ½-inch, 29-gauge (0.33 mm × 12.7 mm) needles, and four alcohol swabs. edex® Cartridge 6 Pack contains one reusable edex® injection device, six single-dose, dual-chamber cartridges, six ½-inch, 29-gauge (0.33 mm × 12.7 mm) needles, and twelve alcohol swabs. The edex® cartridges are supplied in the following packages: Store at 25°C (77°F); excursions permitted between 15°C - 30°C (59°F - 86°F).

Authorization status:

New Drug Application

Summary of Product characteristics

                                EDEX- ALPROSTADIL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
ENDO PHARMACEUTICALS INC.
----------
EDEX
(ALPROSTADIL FOR INJECTION)
FOR INTRACAVERNOUS USE ONLY
STERILE POWDER AND DILUENT
(STERILE 0.9% SODIUM CHLORIDE) IN CARTRIDGES
RX ONLY
DESCRIPTION
edex
(alprostadil for injection) is a sterile, pyrogen-free powder
containing alprostadil in
an alfadex (α-cyclodextrin) inclusion complex. Alprostadil is an
endogenous substance
known as prostaglandin E (PGE ). edex
is supplied in single-dose, dual-chamber
cartridges.
edex
is lyophilized in single-dose, dual-chamber cartridges intended for
use with the
reusable edex
injection device. One chamber of the cartridge contains alprostadil,
alfadex and lactose as a sterile, pyrogen-free powder. The other
chamber contains
1.075 mL of sterile 0.9% sodium chloride. The edex
cartridges are supplied in three
strengths: 10-mcg cartridge (10.75 mcg alprostadil, 347.55 mcg
α-cyclodextrin, 51.06
mg lactose); 20-mcg cartridge (21.5 mcg alprostadil, 695.2 mcg
α-cyclodextrin, 51.06
mg lactose); 40-mcg cartridge (43 mcg alprostadil, 1,390.3 mcg
α-cyclodextrin, 51.06
mg lactose). The edex
injection device is used to reconstitute the sterile powder in one
chamber with the sterile 0.9% sodium chloride in the other chamber.
After
reconstitution, the edex
injection device is used to administer the intracavernous
injection of alprostadil.
The chemical name for alprostadil is
(1R,2R,3R)-3-Hydroxy-2-[(E)-(3S)-3-hydroxy-1-
octenyl]-5-oxocyclopentane heptanoic acid. The empirical formula is C
H
O and the
molecular weight is 354.49. The chemical structure is:
The α-cyclodextrin inclusion complex improves the water solubility of
alprostadil. The
empirical formula of α-cyclodextrin is C
H
O
and the molecular weight is 972.85.
The chemical structure is:
®
®
1
1
®
®
®
®
®
®
20
34
5
36
60
30
Alprostadil alfadex is a white, odorless, hygroscopic powder. It is
freely soluble in water
and practically insoluble in ethanol, ethyl acetate and ether. After
reconstitution, the
active ingredien
                                
                                Read the complete document
                                
                            

Search alerts related to this product